The Generics Bulletin Podcast: Recent And Upcoming Industry Events
Our Editorial Team Discusses Conferences From Recent Months Through Into Early 2025
Executive Summary
Generics Bulletin’s editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent industry events that are on the calendar over the next few months and beyond.
This edition of the Generics Bulletin podcast sees editor Dave Wallace, deputy editor Dean Rudge and reporters Urtė Fultinavičiūtė and Adam Zamecnik discuss recent off-patent industry events such as the legal and annual conferences held by Medicines for Europe in Dublin in June and the annual meeting of the US Association for Accessible Medicines earlier this year, while also looking ahead to the key off-patent industry events on the calendar over the next few months and beyond.
Generics Bulletin reported on Medicines for Europe’s June conferences in a series of articles published earlier this year. (Also see "Medicines For Europe Highlights Sector Challenges As It Celebrates Milestone Anniversary" - Generics Bulletin, 17 Jun, 2024.)
This included a detailed report on the concluding panel of industry leaders. (Also see "The View From The Top: European CEOs Highlight Industry Priorities" - Generics Bulletin, 27 Jun, 2024.)
We also previously brought you coverage from the AAM’s annual conference, including an interview with chair Keren Haruvi. (Also see "‘Is The Market Now Sustainable? The Answer Is Still Not’: AAM’s Haruvi On The Need To Fix The US Generics Industry" - Generics Bulletin, 13 Feb, 2024.)
The AAM event also closed with a leaders’ panel. (Also see "The Long Read: CEOs Unplug At AAM Conference" - Generics Bulletin, 15 Feb, 2024.)